{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:52:47Z","timestamp":1787687567629,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-992","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:12:29Z","timestamp":1434611549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["INTRAGO: intraoperative radiotherapy in glioblastoma multiforme \u2013 a Phase I\/II dose escalation study"],"prefix":"10.1186","volume":"14","author":[{"given":"Frank A","family":"Giordano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Brehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Abo-Madyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grit","family":"Welzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sperk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Herskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schmiedek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,22]]},"reference":[{"issue":"10","key":"5159_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005, 352 (10): 987-996. 10.1056\/NEJMoa043330.","journal-title":"N Engl J Med"},{"issue":"5","key":"5159_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009, 10 (5): 459-466. 10.1016\/S1470-2045(09)70025-7.","journal-title":"Lancet Oncol"},{"issue":"6","key":"5159_CR3","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/0360-3016(89)90941-3","volume":"16","author":"KE Wallner","year":"1989","unstructured":"Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1989, 16 (6): 1405-1409. 10.1016\/0360-3016(89)90941-3.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5159_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0360-3016(92)91021-E","volume":"24","author":"LE Gaspar","year":"1992","unstructured":"Gaspar LE, Fisher BJ, Macdonald DR, LeBer DV, Halperin EC, Schold SC, Cairncross JG: Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment. Int J Radiat Oncol Biol Phys. 1992, 24 (1): 55-57. 10.1016\/0360-3016(92)91021-E.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"5159_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3171\/jns.1986.65.5.0654","volume":"65","author":"AK Choucair","year":"1986","unstructured":"Choucair AK, Levin VA, Gutin PH, Davis RL, Silver P, Edwards MS, Wilson CB: Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg. 1986, 65 (5): 654-658. 10.3171\/jns.1986.65.5.0654.","journal-title":"J Neurosurg"},{"key":"5159_CR6","first-page":"631","volume":"40","author":"J Scherer","year":"1940","unstructured":"Scherer J: The forms of growth in gliomas and their practical significance. Brain. 1940, 40: 631-635.","journal-title":"Brain"},{"issue":"12","key":"5159_CR7","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1073\/pnas.97.12.6242","volume":"97","author":"EC Holland","year":"2000","unstructured":"Holland EC: Glioblastoma multiforme: the terminator. Proc Natl Acad Sci U S A. 2000, 97 (12): 6242-6244. 10.1073\/pnas.97.12.6242.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5159_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11060-012-0983-4","volume":"111","author":"K Petrecca","year":"2013","unstructured":"Petrecca K, Guiot MC, Panet-Raymond V, Souhami L: Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma. J Neurooncol. 2013, 111 (1): 19-23. 10.1007\/s11060-012-0983-4.","journal-title":"J Neurooncol"},{"issue":"5","key":"5159_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","volume":"7","author":"W Stummer","year":"2006","unstructured":"Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006, 7 (5): 392-401. 10.1016\/S1470-2045(06)70665-9.","journal-title":"Lancet Oncol"},{"issue":"2","key":"5159_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.critrevonc.2005.11.004","volume":"59","author":"FA Calvo","year":"2006","unstructured":"Calvo FA, Meirino RM, Orecchia R: Intraoperative radiation therapy first part: rationale and techniques. Crit Rev Oncol Hematol. 2006, 59 (2): 106-115. 10.1016\/j.critrevonc.2005.11.004.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"5159_CR11","doi-asserted-by":"publisher","first-page":"e84991","DOI":"10.1371\/journal.pone.0084991","volume":"9","author":"MR Veldwijk","year":"2014","unstructured":"Veldwijk MR, Zhang B, Wenz F, Herskind C: The biological effect of large single doses: a possible role for non-targeted effects in cell inactivation. PLoS One. 2014, 9 (1): e84991-10.1371\/journal.pone.0084991.","journal-title":"PLoS One"},{"issue":"1","key":"5159_CR12","first-page":"3","volume":"3","author":"C Herskind","year":"2014","unstructured":"Herskind C, Wenz F: Radiobiological aspects of intraoperative tumour-bed irradiation with low-energy X-rays (LEX-IORT). Translational Cancer Research. 2014, 3 (1): 3-17.","journal-title":"Translational Cancer Research"},{"issue":"1","key":"5159_CR13","first-page":"94","volume":"3","author":"FA Giordano","year":"2014","unstructured":"Giordano FA, Abo-Madyan Y, Brehmer S, Herskind C, Sperk E, Schneider F, Clausen S, Welzel G, Schmiedek P, Wenz F: Intraoperative radiotherapy (IORT)\u2014a resurrected option for treating glioblastoma?. Translational Cancer Research. 2014, 3 (1): 94-105.","journal-title":"Translational Cancer Research"},{"issue":"extra","key":"5159_CR14","first-page":"1","volume":"22","author":"P Schueller","year":"2008","unstructured":"Schueller P, Palkovic S, Moustakis C, K\u00f3nemann S, Wassmann H, Willich N: Clinical results and isodose planning of neuronavigation-guided intraoperative radiotherapy (IORT) in 77 brain tumor patients: adequate target volume coverage improve results. Rev Cancer (Madrid). 2008, 22 (extra): 1-58.","journal-title":"Rev Cancer (Madrid)"},{"issue":"8","key":"5159_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s00066-005-1354-2","volume":"181","author":"P Schueller","year":"2005","unstructured":"Schueller P, Micke O, Palkovic S, Schroeder J, Moustakis C, Bruns F, Schuck A, Wassmann H, Willich N: 12\u00a0years' experience with intraoperative radiotherapy (IORT) of malignant gliomas. Strahlenther Onkol. 2005, 181 (8): 500-506. 10.1007\/s00066-005-1354-2.","journal-title":"Strahlenther Onkol"},{"issue":"9917","key":"5159_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","volume":"383","author":"JS Vaidya","year":"2014","unstructured":"Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, Flyger HL, Massarut S, Alvarado M, Saunders C, Eiermann W, Metaxas M, Sperk E, S\u00fctterlin M, Brown D, Esserman L, Roncadin M, Thompson A, Dewar JA, Holtveg HM, Pigorsch S, Falzon M, Harris E, Matthews A, Brew-Graves C, Potyka I, Corica T, Williams NR, Baum M, TARGIT trialists' group: Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014, 383 (9917): 603-613. 10.1016\/S0140-6736(13)61950-9.","journal-title":"Lancet"},{"issue":"3","key":"5159_CR17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ijrobp.2006.01.006","volume":"65","author":"JA Kalapurakal","year":"2006","unstructured":"Kalapurakal JA, Goldman S, Stellpflug W, Curran J, Sathiaseelan V, Marymont MH, Tomita T: Phase I study of intraoperative radiotherapy with photon radiosurgery system in children with recurrent brain tumors: preliminary report of first dose level (10\u00a0Gy). Int J Radiat Oncol Biol Phys. 2006, 65 (3): 800-808. 10.1016\/j.ijrobp.2006.01.006.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 2","key":"5159_CR18","first-page":"449","volume":"27","author":"K Takakura","year":"2000","unstructured":"Takakura K, Kubo O: Treatment of malignant brain tumors. Gan To Kagaku Ryoho. 2000, 27 (Suppl 2): 449-453.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"1","key":"5159_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pdpdt.2011.12.001","volume":"9","author":"M Lyons","year":"2012","unstructured":"Lyons M, Phang I, Eljamel S: The effects of PDT in primary malignant brain tumours could be improved by intraoperative radiotherapy. Photodiagnosis Photodyn Ther. 2012, 9 (1): 40-45. 10.1016\/j.pdpdt.2011.12.001.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"5159_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0167-8140(95)97448-M","volume":"35","author":"JJ Pavy","year":"1995","unstructured":"Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H: EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol. 1995, 35 (1): 11-15. 10.1016\/0167-8140(95)97448-M.","journal-title":"Radiother Oncol"},{"issue":"5","key":"5159_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/0360-3016(95)00059-8","volume":"31","author":"JJ Pavy","year":"1995","unstructured":"Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H: EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys. 1995, 31 (5): 1043-1047. 10.1016\/0360-3016(95)00059-8.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"5159_CR22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1227\/01.NEU.0000333263.31870.31","volume":"63","author":"IM Dequesada","year":"2008","unstructured":"Dequesada IM, Quisling RG, Yachnis A, Friedman WA: Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery. 2008, 63 (5): 898-903. 10.1227\/01.NEU.0000333263.31870.31. discussion 904","journal-title":"Neurosurgery"},{"issue":"4","key":"5159_CR23","first-page":"254","volume":"1","author":"FA Giordano","year":"2012","unstructured":"Giordano FA, Welzel G, Abo-Madyan Y, Wenz F: Potential toxicities of prophylactic cranial irradiation. Translational Lung Cancer Research. 2012, 1 (4): 254-262.","journal-title":"Translational Lung Cancer Research"},{"issue":"11","key":"5159_CR24","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM: Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010, 28 (11): 1963-1972. 10.1200\/JCO.2009.26.3541.","journal-title":"J Clin Oncol"},{"issue":"5","key":"5159_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1470-2045(08)70125-6","volume":"9","author":"D Brandsma","year":"2008","unstructured":"Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ: Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008, 9 (5): 453-461. 10.1016\/S1470-2045(08)70125-6.","journal-title":"Lancet Oncol"},{"issue":"3 Suppl","key":"5159_CR26","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, Bentzen SM, Nam J, Deasy JO: Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010, 76 (3 Suppl): S10-S19.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"5159_CR27","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00066-010-2147-9","volume":"186","author":"C Herskind","year":"2010","unstructured":"Herskind C, Wenz F: Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays. Strahlenther Onkol. 2010, 186 (8): 444-451. 10.1007\/s00066-010-2147-9.","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"5159_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.zemedi.2013.10.006","volume":"24","author":"F Schneider","year":"2014","unstructured":"Schneider F, Clausen S, Jahnke A, Steil V, Bludau F, Sutterlin M, Obertacke U, Wenz F: Radiation protection for an intraoperative x-ray source compared to C-arm fluoroscopy. Z Med Phys. 2014, 24 (3): 243-251. 10.1016\/j.zemedi.2013.10.006.","journal-title":"Z Med Phys"},{"issue":"1\u20132","key":"5159_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/BF01401457","volume":"131","author":"M Matsutani","year":"1994","unstructured":"Matsutani M, Nakamura O, Nagashima T, Asai A, Fujimaki T, Tanaka H, Nakamura M, Ueki K, Tanaka Y, Matsuda T: Intra-operative radiation therapy for malignant brain tumors: rationale, method, and treatment results of cerebral glioblastomas. Acta Neurochir (Wien). 1994, 131 (1\u20132): 80-90.","journal-title":"Acta Neurochir (Wien)"},{"issue":"4","key":"5159_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.2176\/nmc.29.312","volume":"29","author":"N Sakai","year":"1989","unstructured":"Sakai N, Yamada H, Andoh T, Takada M, Hirata T, Funakoshi T, Doi H, Yanagawa S: Intraoperative radiation therapy for malignant glioma. Neurol Med Chir (Tokyo). 1989, 29 (4): 312-318. 10.2176\/nmc.29.312.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"5159_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF01058463","volume":"23","author":"T Fujiwara","year":"1995","unstructured":"Fujiwara T, Honma Y, Ogawa T, Irie K, Kuyama H, Nagao S, Takashima H, Hosokawa A, Ohkawa M, Tanabe M: Intraoperative radiotherapy for gliomas. J Neurooncol. 1995, 23 (1): 81-86. 10.1007\/BF01058463.","journal-title":"J Neurooncol"},{"issue":"5","key":"5159_CR32","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/00000421-199410000-00008","volume":"17","author":"Y Shibamoto","year":"1994","unstructured":"Shibamoto Y, Yamashita J, Takahashi M, Abe M: Intraoperative radiation therapy for brain tumors with emphasis on retreatment for recurrence following full-dose external beam irradiation. Am J Clin Oncol. 1994, 17 (5): 396-399. 10.1097\/00000421-199410000-00008.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"5159_CR33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/01616412.1995.11740329","volume":"17","author":"D Ortiz de Urbina","year":"1995","unstructured":"Ortiz de Urbina D, Santos M, Garcia-Berrocal I, Bustos JC, Samblas J, Gutierrez-Diaz JA, Delgado JM, Donckaster G, Calvo FA: Intraoperative radiation therapy in malignant glioma: early clinical results. Neurol Res. 1995, 17 (4): 289-294.","journal-title":"Neurol Res"},{"key":"5159_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-2-1","volume":"2","author":"K Nemoto","year":"2002","unstructured":"Nemoto K, Ogawa Y, Matsushita H, Takeda K, Takai Y, Yamada S, Kumabe T: Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas. BMC Cancer. 2002, 2: 1-10.1186\/1471-2407-2-1.","journal-title":"BMC Cancer"},{"issue":"3","key":"5159_CR35","first-page":"154","volume":"171","author":"W Wagner","year":"1995","unstructured":"Wagner W, Schuller P, Willich N, Schober O, Palkovic S, Morgenroth C, Bartenstein P, Prott FJ, Niewohner U: Intraoperative radiotherapy (IORT) in malignant brain tumors. Strahlenther Onkol. 1995, 171 (3): 154-164.","journal-title":"Strahlenther Onkol"},{"key":"5159_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000061152","volume":"31","author":"J Gouda","year":"1997","unstructured":"Gouda J, Brown J, Carter D, Dobelbower RR: Malignant brain tumors treated with IORT. Front Radiat Ther Oncol. 1997, 31: 87-91.","journal-title":"Front Radiat Ther Oncol"},{"issue":"11","key":"5159_CR37","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2176\/nmc.31.702","volume":"31","author":"N Sakai","year":"1991","unstructured":"Sakai N, Yamada H, Andoh T, Hirata T, Nishimura Y, Miwa Y, Shimizu K, Yanagawa S: Intraoperative radiation therapy for malignant glioma. Neurol Med Chir (Tokyo). 1991, 31 (11): 702-707. 10.2176\/nmc.31.702.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"3","key":"5159_CR38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ijrobp.2004.04.011","volume":"60","author":"L Souhami","year":"2004","unstructured":"Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93\u201305 protocol. Int J Radiat Oncol Biol Phys. 2004, 60 (3): 853-860. 10.1016\/j.ijrobp.2004.04.011.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5159_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.clon.2005.08.017","volume":"18","author":"NG Burnet","year":"2006","unstructured":"Burnet NG, Jena R, Jefferies SJ, Stenning SP, Kirkby NF: Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol). 2006, 18 (2): 93-103. 10.1016\/j.clon.2005.08.017.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"2","key":"5159_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0167-8140(00)00257-7","volume":"57","author":"V Do","year":"2000","unstructured":"Do V, Gebski V, Barton MB: The effect of waiting for radiotherapy for grade III\/IV gliomas. Radiother Oncol. 2000, 57 (2): 131-136. 10.1016\/S0167-8140(00)00257-7.","journal-title":"Radiother Oncol"},{"issue":"10","key":"5159_CR41","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/0360-3016(79)90553-4","volume":"5","author":"MD Walker","year":"1979","unstructured":"Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys. 1979, 5 (10): 1725-1731. 10.1016\/0360-3016(79)90553-4.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"5159_CR42","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/bjc.1991.396","volume":"64","author":"NM Bleehen","year":"1991","unstructured":"Bleehen NM, Stenning SP: A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer. 1991, 64 (4): 769-774. 10.1038\/bjc.1991.396.","journal-title":"Br J Cancer"},{"issue":"3","key":"5159_CR43","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ijrobp.2008.05.034","volume":"73","author":"C Tsien","year":"2009","unstructured":"Tsien C, Moughan J, Michalski JM, Gilbert MR, Purdy J, Simpson J, Kresel JJ, Curran WJ, Diaz A, Mehta MP: Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98\u201303. Int J Radiat Oncol Biol Phys. 2009, 73 (3): 699-708. 10.1016\/j.ijrobp.2008.05.034.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5159_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1158\/1078-0432.CCR-11-2073","volume":"18","author":"CI Tsien","year":"2012","unstructured":"Tsien CI, Brown D, Normolle D, Schipper M, Piert M, Junck L, Heth J, Gomez-Hassan D, Ten Haken RK, Chenevert T, et al: Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res. 2012, 18 (1): 273-279. 10.1158\/1078-0432.CCR-11-2073.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"5159_CR45","first-page":"1996","volume":"49","author":"B Fisher","year":"1989","unstructured":"Fisher B, Gunduz N, Coyle J, Rudock C, Saffer E: Presence of a growth-stimulating factor in serum following primary tumor removal in mice. Cancer Res. 1989, 49 (8): 1996-2001.","journal-title":"Cancer Res"},{"issue":"5","key":"5159_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1067\/msy.2003.141","volume":"133","author":"Y Tsuchiya","year":"2003","unstructured":"Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya Y, Tsukada K, Saiki I: Increased surgical stress promotes tumor metastasis. Surgery. 2003, 133 (5): 547-555. 10.1067\/msy.2003.141.","journal-title":"Surgery"},{"issue":"5","key":"5159_CR47","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1158\/1078-0432.CCR-07-4453","volume":"14","author":"B Belletti","year":"2008","unstructured":"Belletti B, Vaidya JS, D'Andrea S, Entschladen F, Roncadin M, Lovat F, Berton S, Perin T, Candiani E, Reccanello S, et al: Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res. 2008, 14 (5): 1325-1332. 10.1158\/1078-0432.CCR-07-4453.","journal-title":"Clin Cancer Res"},{"key":"5159_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-3-211-85578-2_85","volume":"102","author":"JC Goodman","year":"2008","unstructured":"Goodman JC, Van M, Gopinath SP, Robertson CS: Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury. Acta Neurochir Suppl. 2008, 102: 437-439. 10.1007\/978-3-211-85578-2_85.","journal-title":"Acta Neurochir Suppl"},{"issue":"10","key":"5159_CR49","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/neu.2007.0295","volume":"24","author":"PJ Hutchinson","year":"2007","unstructured":"Hutchinson PJ, O'Connell MT, Rothwell NJ, Hopkins SJ, Nortje J, Carpenter KL, Timofeev I, Al-Rawi PG, Menon DK, Pickard JD: Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma. 2007, 24 (10): 1545-1557. 10.1089\/neu.2007.0295.","journal-title":"J Neurotrauma"},{"issue":"1\u20132","key":"5159_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.physbeh.2007.05.050","volume":"92","author":"M Schultzberg","year":"2007","unstructured":"Schultzberg M, Lindberg C, Aronsson AF, Hjorth E, Spulber SD, Oprica M: Inflammation in the nervous system\u2013physiological and pathophysiological aspects. Physiol Behav. 2007, 92 (1\u20132): 121-128.","journal-title":"Physiol Behav"},{"issue":"2","key":"5159_CR51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","volume":"67","author":"J Gonzalez","year":"2007","unstructured":"Gonzalez J, Kumar AJ, Conrad CA, Levin VA: Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys. 2007, 67 (2): 323-326. 10.1016\/j.ijrobp.2006.10.010.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5159_CR52","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M: Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991, 21 (1): 109-122. 10.1016\/0360-3016(91)90171-Y.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5159_CR53","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1667\/RR3292","volume":"163","author":"C Herskind","year":"2005","unstructured":"Herskind C, Steil V, Kraus-Tiefenbacher U, Wenz F: Radiobiological aspects of intraoperative radiotherapy (IORT) with isotropic low-energy X rays for early-stage breast cancer. Radiat Res. 2005, 163 (2): 208-215. 10.1667\/RR3292.","journal-title":"Radiat Res"},{"issue":"1","key":"5159_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11060-006-9241-y","volume":"82","author":"MC Chamberlain","year":"2007","unstructured":"Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE: Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol. 2007, 82 (1): 81-83. 10.1007\/s11060-006-9241-y.","journal-title":"J Neurooncol"},{"issue":"1","key":"5159_CR55","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/00001813-199701000-00013","volume":"8","author":"SR Wedge","year":"1997","unstructured":"Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES: In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs. 1997, 8 (1): 92-97. 10.1097\/00001813-199701000-00013.","journal-title":"Anticancer Drugs"},{"issue":"3","key":"5159_CR56","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0360-3016(99)00539-8","volume":"47","author":"J van Rijn","year":"2000","unstructured":"van Rijn J, Heimans JJ, van den Berg J, van der Valk P, Slotman BJ: Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys. 2000, 47 (3): 779-784. 10.1016\/S0360-3016(99)00539-8.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-992.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-992\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T13:58:58Z","timestamp":1498226338000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["5159"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-992","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"article-number":"992"}}